AbbVie Inc. Operating Cash Flow 2011-2026 | ABBV
Beta
What is operating cash flow?
Operating cash flow can be defined as the cash generated from a company's normal business operations, reflecting the ability to generate cash from core activities.
What is AbbVie Inc.'s current operating cash flow?
AbbVie Inc. (ABBV) annual operating cash flow for 2025 was $19.03B, a 1.19% increase from 2024. AbbVie Inc. operating cash flow for the quarter ending March 31, 2026 was $3.83B.
What was AbbVie Inc.'s operating cash flow in 2024?
AbbVie Inc. annual operating cash flow for 2024 was $18.81B, a 17.66% decline from 2023.
What was AbbVie Inc.'s operating cash flow in 2023?
AbbVie Inc. annual operating cash flow for 2023 was $22.84B, a 8.44% decline from 2022.
What is AbbVie Inc.'s 5-year operating cash flow CAGR?
AbbVie Inc. operating cash flow grew at a compound annual growth rate (CAGR) of 1.59% from FY2020 to FY2025, going from $17.59B to $19.03B over 5 years.
Operating Cash Flow History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR+1.6%
FY2020
$17.59B
→
FY2025
$19.03B
111213141516171819202122232425
5 years selected
Operating Cash Flow History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $19.03B | +1.2% | 10-K |
| FY2024 | $18.81B | -17.7% | 10-K |
| FY2023 | $22.84B | -8.4% | 10-K |
| FY2022 | $24.94B | +9.5% | 10-K |
| FY2021 | $22.78B | +29.5% | 10-K |
| FY2020 | $17.59B | +32.0% | 10-K |
| FY2019 | $13.32B | -0.8% | 10-K |
| FY2018 | $13.43B | +34.8% | 10-K |
| FY2017 | $9.96B | +41.5% | 10-K |
| FY2016 | $7.04B | -6.6% | 10-K |
| FY2015 | $7.54B | +112.3% | 10-K |
| FY2014 | $3.55B | -43.4% | 10-K |
| FY2013 | $6.27B | -1.2% | 10-K |
| FY2012 | $6.34B | +1.6% | 10-K |
| FY2011 | $6.25B | - | 10-K |
Company: AbbVie Inc.Ticker: ABBVSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →